Getting your Ozempic , Wegovy , or semaglutide in 3 easy steps Affordable, easy-to-use care at your fingertips Answer some questions to see if you're eligible Tell us more about yourself and confirm that you are eligible for our clinically effective Zealthy Weight Loss Program
People who took semaglutide lost, on average, 3.6% of their body weight after 3 months
These adverse reactions occurred more commonly on OZEMPIC than on placebo and occurred in at least 5% of patients treated with OZEMPIC
Factor the dead space loss into your vial dose calculations, especially if you are tracking cost per dose
The primary endpoint was major adverse cardiovascular events (MACE), defined as cardiovascular death, nonfatal heart attack, or nonfatal stroke